@article{2f4a6a36ffd343649bfa2d4ef8525e73,
title = "COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial",
keywords = "COVID-19/complications, Cyclophosphamide/therapeutic use, Dexamethasone/therapeutic use, Humans, Multiple Myeloma/complications, Oligopeptides/therapeutic use, Stem Cell Transplantation",
author = "Elizabeth Phillips",
note = "Funding Information: CARDAMON is coordinated by the CRUK \& UCL CTC, funded by Amgen Ltd and endorsed by Cancer Research UK (C9203/A17750). The authors would like to thank CARDAMON participating sites, local investigators and research teams for their ongoing participation in the study, together with patients and their families. Funding Information: Professor Kwee Yong and Dr Rakesh Popat acknowledge support and funding from the UCL/UCLH National Institute for Health Research and Social Care (NIHR) Biomedical Research. Funding Information: CARDAMON is coordinated by the CRUK \& UCL CTC, funded by Amgen Ltd and endorsed by Cancer Research UK (C9203/A17750). The authors would like to thank CARDAMON participating sites, local investigators and research teams for their ongoing participation in the study, together with patients and their families. Professor Kwee Yong and Dr Rakesh Popat acknowledge support and funding from the UCL/UCLH National Institute for Health Research and Social Care (NIHR) Biomedical Research. Professor Barrington also acknowledges support from the NIHR (RP-2-16-07-001). King?s College London and UCL Comprehensive Cancer Imaging Centre is funded by the CRUK and EPSRC in association with the MRC and Department of Health and Social Care (England). This work was also supported by the Wellcome/EPSRC Centre for Medical Engineering at King?s College London (WT 203148/Z/16/Z). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Funding Information: Professor Barrington also acknowledges support from the NIHR (RP‐2‐16‐07‐001). King{\textquoteright}s College London and UCL Comprehensive Cancer Imaging Centre is funded by the CRUK and EPSRC in association with the MRC and Department of Health and Social Care (England). This work was also supported by the Wellcome/EPSRC Centre for Medical Engineering at King{\textquoteright}s College London (WT 203148/Z/16/Z). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.",
year = "2020",
month = dec,
day = "20",
doi = "10.1111/bjh.17168",
language = "English",
volume = "192",
pages = "e14--e16",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley \& Sons Ltd",
number = "1",
}
